STOCK TITAN

Fortrea (FTRE) Form 144 Filed for 3,156-Share Sale After Vesting

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
144

Rhea-AI Filing Summary

Fortrea Holdings (FTRE) Form 144 notice shows a proposed sale of 3,156 common shares through Fidelity Brokerage (Smithfield, RI) on 09/09/2025 with an aggregate market value of $32,283.04. The shares were acquired on 09/08/2025 as restricted stock vesting and paid as compensation. The filing reports 90,800,000 shares outstanding for the class. It also discloses a prior sale by Jill G. Mcconnell of 4,886 shares on 08/19/2025 for $39,160.31. The notice includes the signer’s representation that no undisclosed material adverse information exists.

Positive

  • Shares acquired via restricted stock vesting, indicating alignment of compensation with company performance
  • Insider attestation that no undisclosed material adverse information exists as part of the filing

Negative

  • None.

Insights

TL;DR: Small insider sale request after recent restricted stock vesting; amounts are immaterial relative to outstanding shares.

The filing documents a proposed sale of 3,156 common shares valued at $32,283.04 following restricted stock vesting on 09/08/2025. Relative to the reported 90.8 million shares outstanding, the transaction size is negligible and unlikely to affect market supply or valuation materially. The filing also discloses a prior sale of 4,886 shares for $39,160.31 on 08/19/2025, which suggests routine disposition of vested compensation rather than a large-scale exit.

TL;DR: Transaction appears consistent with compensation vesting and routine insider liquidity; no governance red flags disclosed.

The report indicates the shares to be sold were acquired as restricted stock vesting and paid as compensation, a common executive compensation mechanism. The filer affirms no undisclosed material adverse information and includes the standard Rule 144 representation. There is no indication of unusual transfer mechanisms, related-party counterparties, or aggregated large disposals that would raise governance concerns.

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

FAQ

What shares of FTRE are proposed for sale in this Form 144?

The notice proposes the sale of 3,156 common shares on 09/09/2025 through Fidelity Brokerage, valued at $32,283.04.

How and when were the shares to be sold acquired?

The 3,156 shares were acquired on 09/08/2025 through restricted stock vesting and the payment was for compensation.

Has the filer sold FTRE shares recently?

Yes. The filing discloses a prior sale by Jill G. Mcconnell of 4,886 common shares on 08/19/2025 for $39,160.31.

How large are these transactions relative to FTRE's outstanding shares?

The class has 90,800,000 shares outstanding, so the proposed sale of 3,156 shares is immaterial in size relative to total outstanding shares.

Does the Form 144 include any disclaimer about material information?

Yes. The signer represents they do not know of any material adverse information regarding the issuer that has not been publicly disclosed.
Fortrea Holdings

NASDAQ:FTRE

FTRE Rankings

FTRE Latest News

FTRE Latest SEC Filings

FTRE Stock Data

1.64B
91.87M
0.5%
111.46%
11.57%
Biotechnology
Services-medical Laboratories
Link
United States
DURHAM